APO RESEARCH · REPORT
Cardiac Stent
A Cardiac Stent (also called coronary stent) is a tube-shaped device placed in the coronary arteries that supply blood to the heart, to keep the arteries open in the treatment of coronary heart disease. It is used in a procedure called percutaneous coronary intervention (PCI).
Product & engineering
Understand the product.
A Cardiac Stent (also called coronary stent) is a tube-shaped device placed in the coronary arteries that supply blood to the heart, to keep the arteries open in the treatment of coronary heart disease. It is used in a procedure called percutaneous coronary intervention (PCI).
Selected research
Industry Research
Cardiac Stent Industry Research Report 2026
Market perspective
A Cardiac Stent (also called coronary stent) is a tube-shaped device placed in the coronary arteries that supply blood to the heart, to keep the arteries open in the treatment of coronary heart disease. It is used in a procedure called percutaneous coronary intervention (PCI).
The global PCI device market is projected to gain growth on the back of the prevalence of cardiovascular diseases and the aging process. The global Cardiac Stent market is forecasted to keep the trend.
As the technology of Cardiac Stent is relatively mature and the downstream market, especially for Angina application is growing fast, so there are lots of enterprises in the Cardiac Stent market. The Cardiac Stent market competition will be still intense. Abbott Vascular is the leading manufacturer in the global Cardiac Stent market with the market share of 24.95%, in terms of revenue, followed by Boston Scientific, Medtronic, Terumo (ESSEN), Lepu Medical, MicroPort, Biosensors, B.Braun, Atrium Medical, Biotronik, and SINOMED. These leading 11 companies accounted for 96% of the market share in 2019.
Read the full market overview
Report Scope
This report quantifies the global Cardiac Stent market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cardiac Stent Market by Company
Abbott Vascular
Boston Scientific
Medtronic
Terumo (ESSEN)
Lepu Medical
MicroPort
Biosensors
B.Braun
Atrium Medical
Biotronik
SINOMED
Cardiac Stent Segment by Type
Bare-metal Stent (BMS)
Drug-eluting Stent (DES)
Bioresorbable Vascular Scaffold (BVS)
Cardiac Stent Segment by Application
Angina
Myocardial Infarction
Other Disease
Cardiac Stent Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiac Stent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cardiac Stent and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiac Stent.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cardiac Stent manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cardiac Stent by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cardiac Stent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Bare-metal Stent (BMS)
- Drug-eluting Stent (DES)
- Bioresorbable Vascular Scaffold (BVS)
Applications
- Angina
- Myocardial Infarction
- Other Disease
Companies covered
- Abbott Vascular
- Boston Scientific
- Medtronic
- Terumo (ESSEN)
- Lepu Medical
- MicroPort
- Biosensors
- B.Braun
- Atrium Medical
- Biotronik
- SINOMED
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cardiac Stent Market Size (2021-2032)
- 2.2.2 Global Cardiac Stent Sales (2021-2032)
- 2.2.3 Global Cardiac Stent Market Average Price (2021-2032)
- 2.3 Cardiac Stent by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Bare-metal Stent (BMS)
- 2.3.3 Drug-eluting Stent (DES)
- 2.3.4 Bioresorbable Vascular Scaffold (BVS)
- 2.4 Cardiac Stent by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Angina
- 2.4.3 Myocardial Infarction
- 2.4.4 Other Disease
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cardiac Stent Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cardiac Stent Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Cardiac Stent Revenue of Manufacturers (2021-2026)
- 3.4 Global Cardiac Stent Average Price by Manufacturers (2021-2026)
- 3.5 Global Cardiac Stent Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cardiac Stent, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cardiac Stent, Product Type & Application
- 3.8 Global Manufacturers of Cardiac Stent, Established Date
- 3.9 Global Cardiac Stent Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott Vascular
- 4.1.1 Abbott Vascular Company Information
- 4.1.2 Abbott Vascular Business Overview
- 4.1.3 Abbott Vascular Cardiac Stent Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott Vascular Cardiac Stent Product Portfolio
- 4.1.5 Abbott Vascular Recent Developments
- 4.2 Boston Scientific
- 4.2.1 Boston Scientific Company Information
- 4.2.2 Boston Scientific Business Overview
- 4.2.3 Boston Scientific Cardiac Stent Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Boston Scientific Cardiac Stent Product Portfolio
- 4.2.5 Boston Scientific Recent Developments
- 4.3 Medtronic
- 4.3.1 Medtronic Company Information
- 4.3.2 Medtronic Business Overview
- 4.3.3 Medtronic Cardiac Stent Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Medtronic Cardiac Stent Product Portfolio
- 4.3.5 Medtronic Recent Developments
- 4.4 Terumo (ESSEN)
- 4.4.1 Terumo (ESSEN) Company Information
- 4.4.2 Terumo (ESSEN) Business Overview
- 4.4.3 Terumo (ESSEN) Cardiac Stent Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Terumo (ESSEN) Cardiac Stent Product Portfolio
- 4.4.5 Terumo (ESSEN) Recent Developments
- 4.5 Lepu Medical
- 4.5.1 Lepu Medical Company Information
- 4.5.2 Lepu Medical Business Overview
- 4.5.3 Lepu Medical Cardiac Stent Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Lepu Medical Cardiac Stent Product Portfolio
- 4.5.5 Lepu Medical Recent Developments
- 4.6 MicroPort
- 4.6.1 MicroPort Company Information
- 4.6.2 MicroPort Business Overview
- 4.6.3 MicroPort Cardiac Stent Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 MicroPort Cardiac Stent Product Portfolio
- 4.6.5 MicroPort Recent Developments
- 4.7 Biosensors
- 4.7.1 Biosensors Company Information
- 4.7.2 Biosensors Business Overview
- 4.7.3 Biosensors Cardiac Stent Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Biosensors Cardiac Stent Product Portfolio
- 4.7.5 Biosensors Recent Developments
- 4.8 B.Braun
- 4.8.1 B.Braun Company Information
- 4.8.2 B.Braun Business Overview
- 4.8.3 B.Braun Cardiac Stent Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 B.Braun Cardiac Stent Product Portfolio
- 4.8.5 B.Braun Recent Developments
- 4.9 Atrium Medical
- 4.9.1 Atrium Medical Company Information
- 4.9.2 Atrium Medical Business Overview
- 4.9.3 Atrium Medical Cardiac Stent Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Atrium Medical Cardiac Stent Product Portfolio
- 4.9.5 Atrium Medical Recent Developments
- 4.10 Biotronik
- 4.10.1 Biotronik Company Information
- 4.10.2 Biotronik Business Overview
- 4.10.3 Biotronik Cardiac Stent Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Biotronik Cardiac Stent Product Portfolio
- 4.10.5 Biotronik Recent Developments
- 4.11 SINOMED
- 4.11.1 SINOMED Company Information
- 4.11.2 SINOMED Business Overview
- 4.11.3 SINOMED Cardiac Stent Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 SINOMED Cardiac Stent Product Portfolio
- 4.11.5 SINOMED Recent Developments
5 Global Cardiac Stent Market Scenario by Region
- 5.1 Global Cardiac Stent Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cardiac Stent Sales by Region: 2021-2032
- 5.2.1 Global Cardiac Stent Sales by Region: 2021-2026
- 5.2.2 Global Cardiac Stent Sales by Region: 2027-2032
- 5.3 Global Cardiac Stent Revenue by Region: 2021-2032
- 5.3.1 Global Cardiac Stent Revenue by Region: 2021-2026
- 5.3.2 Global Cardiac Stent Revenue by Region: 2027-2032
- 5.4 North America Cardiac Stent Market Facts & Figures by Country
- 5.4.1 North America Cardiac Stent Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cardiac Stent Sales by Country (2021-2032)
- 5.4.3 North America Cardiac Stent Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Cardiac Stent Market Facts & Figures by Country
- 5.5.1 Europe Cardiac Stent Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cardiac Stent Sales by Country (2021-2032)
- 5.5.3 Europe Cardiac Stent Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Cardiac Stent Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cardiac Stent Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cardiac Stent Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cardiac Stent Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cardiac Stent Market Facts & Figures by Country
- 5.7.1 South America Cardiac Stent Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cardiac Stent Sales by Country (2021-2032)
- 5.7.3 South America Cardiac Stent Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Cardiac Stent Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cardiac Stent Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cardiac Stent Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cardiac Stent Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Cardiac Stent Sales by Type (2021-2032)
- 6.1.1 Global Cardiac Stent Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Cardiac Stent Sales Market Share by Type (2021-2032)
- 6.2 Global Cardiac Stent Revenue by Type (2021-2032)
- 6.2.1 Global Cardiac Stent Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cardiac Stent Revenue Market Share by Type (2021-2032)
- 6.3 Global Cardiac Stent Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cardiac Stent Sales by Application (2021-2032)
- 7.1.1 Global Cardiac Stent Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Cardiac Stent Sales Market Share by Application (2021-2032)
- 7.2 Global Cardiac Stent Revenue by Application (2021-2032)
- 7.2.1 Global Cardiac Stent Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cardiac Stent Revenue Market Share by Application (2021-2032)
- 7.3 Global Cardiac Stent Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cardiac Stent Value Chain Analysis
- 8.1.1 Cardiac Stent Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cardiac Stent Production Mode & Process
- 8.2 Cardiac Stent Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cardiac Stent Distributors
- 8.2.3 Cardiac Stent Customers
9 Global Cardiac Stent Analyzing Market Dynamics
- 9.1 Cardiac Stent Industry Trends
- 9.2 Cardiac Stent Industry Drivers
- 9.3 Cardiac Stent Industry Opportunities and Challenges
- 9.4 Cardiac Stent Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst